Hereditary Cancer PanelClinically indicated
Hereditary cancer germline panel
Eligible individuals with suggestive personal or family history
Specimen / data: Blood or saliva
BRCA1/2 GermlineClinically indicated
Germline BRCA1/2 testing
Personal or family history consistent with hereditary breast/ovarian cancer
Specimen / data: Blood or saliva
MMR Germline PanelClinically indicated
Lynch syndrome germline panel
Suspected Lynch syndrome based on clinical and, where appropriate, tumor findings
Specimen / data: Blood or saliva
Targeted Cascade TestingClinically indicated
Familial-variant cascade test
Relatives of a carrier of a known inherited variant
Specimen / data: Blood or saliva
MMR IHC / MSIComplementary tumor test
Tumor MMR/MSI screening
Investigating mismatch repair deficiency in selected tumors, including colorectal or endometrial cancer; not a germline diagnosis
Specimen / data: Tumor tissue
Multi-Cancer Early DetectionEmerging; limited evidence of clinical benefit
Multi-cancer early detection (MCED)
Molecular signal detection across multiple cancers in asymptomatic populations; not a substitute for standard screening
Specimen / data: Usually blood